Quarterly ResultMay 1, 2026, 03:36 PM
Encompass Health Q1 Net Income $194.5M; EPS $1.93
AI Summary
Encompass Health reported strong first-quarter results for 2026, with net operating revenues increasing by 9.0% to $1.59 billion and net income attributable to the company rising by 28.4% to $194.5 million. Diluted earnings per share grew by 30.4% to $1.93. The company also recognized a $17.5 million pre-tax gain from the sale of its Gamma Knife Center interest and a $16.3 million after-tax gain from a litigation settlement related to discontinued operations. Additionally, Encompass Health entered into a new credit agreement with improved terms.
Key Highlights
- Net operating revenues increased 9.0% to $1,586.6 million for Q1 2026.
- Net income attributable to Encompass Health rose 28.4% to $194.5 million.
- Diluted earnings per share grew 30.4% to $1.93.
- Net cash provided by operating activities increased 8.5% to $313.1 million.
- Recognized a $17.5 million pre-tax gain from the sale of Gamma Knife Center interest.
- Recorded a $16.3 million after-tax gain from a litigation settlement.
- Entered a new credit agreement with improved terms and extended maturity to March 2031.
- Declared dividends of $0.19 per share, up from $0.17 per share.
- Repurchased $71.6 million of common stock in Q1 2026.
Price Impact
More from EHC